ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 538,29
-0,30%
Dow Jones
39 331,85
0,41%
DAX
18 164,06
-0,86%
Brent Oil
86,45
0,01%
Bitcoin
61 480,60
-0,88%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Scinai Immunotherapeutics Ltd (SCNI)

  7. Scinai Immunotherapeutics Ltd (SCNI) Actualités

SCNI

Scinai Immunotherapeutics (SCNI)

Scinai Immunotherapeutics Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:SCNI
DateHeureSourceTitreSymboleSociété
02/07/202414h12PR Newswire (US)Scinai Publishes Q1 2024 Financial Results and Provides Business UpdateNASDAQ:SCNIScinai Immunotherapeutics Ltd
14/06/202413h26Edgar (US Regulatory)Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]NASDAQ:SCNIScinai Immunotherapeutics Ltd
13/06/202413h00PR Newswire (US)Scinai Immunotherapeutics Announces Receipt of a Letter of Intent from the European Investment Bank Providing Specific Terms for Conversion of its Loan to Equity.NASDAQ:SCNIScinai Immunotherapeutics Ltd
07/06/202413h00PR Newswire (US)Scinai Immunotherapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement; Continues to Work with the European Investment Bank to Convert Loan to Equity to Regain Compliance with Nasdaq Minimum Shareholders' Equity RequirementNASDAQ:SCNIScinai Immunotherapeutics Ltd
24/05/202422h01PR Newswire (US)Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining ComplianceNASDAQ:SCNIScinai Immunotherapeutics Ltd
16/05/202419h49Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:SCNIScinai Immunotherapeutics Ltd
15/05/202422h01PR Newswire (US)Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business UpdateNASDAQ:SCNIScinai Immunotherapeutics Ltd
06/05/202415h21PR Newswire (US)Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and AppealNASDAQ:SCNIScinai Immunotherapeutics Ltd
10/04/202413h00PR Newswire (US)Scinai to showcase its novel biological local therapeutic for Plaque Psoriasis at Dermatology Drug Development Summit together with Prof. Michael Schön of UMGNASDAQ:SCNIScinai Immunotherapeutics Ltd
08/04/202423h15AllPennyStocks.comBiotech Rips Following Five-Year Master Service Agreement ReleaseNASDAQ:SCNIScinai Immunotherapeutics Ltd
08/04/202413h00PR Newswire (US)Scinai Immunotherapeutics' CDMO Unit Selected by Ayana Pharma to Provide Drug Development and cGMP Manufacturing ServicesNASDAQ:SCNIScinai Immunotherapeutics Ltd
12/03/202413h00PR Newswire (US)Scinai leadership to attend BIO-Europe Spring 2024NASDAQ:SCNIScinai Immunotherapeutics Ltd
29/02/202414h45PR Newswire (US)Scinai to showcase its cGMP biologics CDMO and innovative NanoAb pipeline at MIXiii 2024NASDAQ:SCNIScinai Immunotherapeutics Ltd
13/02/202413h00PR Newswire (US)Scinai Welcomes Liat Halpert as Head of Business Development and SalesNASDAQ:SCNIScinai Immunotherapeutics Ltd
30/01/202422h19Edgar (US Regulatory)Form F-3 - Registration statement by foreign private issuersNASDAQ:SCNIScinai Immunotherapeutics Ltd
25/01/202416h26PR Newswire (US)Scinai Immunotherapeutics Congratulates its Co-Lead Scientific Research Collaborator Dirk Görlich on Louis-Jeantet PrizeNASDAQ:SCNIScinai Immunotherapeutics Ltd
24/01/202420h33Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:SCNIScinai Immunotherapeutics Ltd
12/01/202413h32Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:SCNIScinai Immunotherapeutics Ltd
04/01/202422h01PR Newswire (US)Scinai Immunotherapeutics Announces Closing of Exercise of Outstanding Warrants for $1.69 Million in Gross ProceedsNASDAQ:SCNIScinai Immunotherapeutics Ltd
04/01/202412h15PR Newswire (US)Scinai Immunotherapeutics CEO Issues Letter to ShareholdersNASDAQ:SCNIScinai Immunotherapeutics Ltd
29/12/202315h21PR Newswire (US)Scinai Immunotherapeutics Announces Exercise of Outstanding Warrants for $1.69 Million in Gross ProceedsNASDAQ:SCNIScinai Immunotherapeutics Ltd
27/12/202313h15PR Newswire (US)Scinai (NASDAQ: SCNI) to Host Analyst and Investor Webinar on January 9NASDAQ:SCNIScinai Immunotherapeutics Ltd
27/12/202306h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:SCNIScinai Immunotherapeutics Ltd
22/12/202315h11Edgar (US Regulatory)Form F-1/A - Registration statement for certain foreign private issuers: [Amend]NASDAQ:SCNIScinai Immunotherapeutics Ltd
12/12/202313h26PR Newswire (US)Scinai Announces Promising Results in a Psoriatic Human Skin ModelNASDAQ:SCNIScinai Immunotherapeutics Ltd
11/12/202314h11PR Newswire (US)Study published in Antiviral Research supports promise of Scinai Immunotherapeutics' coronavirus NanoAb as aerosolized prophylactic and therapeutic drugNASDAQ:SCNIScinai Immunotherapeutics Ltd
29/11/202315h25PR Newswire (US)European Investment Bank (EIB) extends maturity of its finance facility with Scinai Immunotherapeutics from 2027 to 2031NASDAQ:SCNIScinai Immunotherapeutics Ltd
20/11/202313h30PR Newswire (US)Scinai Immunotherapeutics Regains Compliance with Nasdaq's Stockholders' Equity RuleNASDAQ:SCNIScinai Immunotherapeutics Ltd
06/11/202313h30GlobeNewswire Inc.Scinai Immunotherapeutics Announces Award of Non-Dilutive Grant from Israel Innovation Authority Supporting its New CDMO Business UnitNASDAQ:SCNIScinai Immunotherapeutics Ltd
03/11/202321h30GlobeNewswire Inc.Scinai Immunotherapeutics Provides Update Regarding Nasdaq ComplianceNASDAQ:SCNIScinai Immunotherapeutics Ltd
 Showing the most relevant articles for your search:NASDAQ:SCNI

Dernières Valeurs Consultées

NASDAQ
TAYC
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés